Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Aernoud T. L. Fiolet"'
Autor:
Niekbachsh Mohammadnia, Jan Los, Tjerk S. J. Opstal, Aernoud T. L. Fiolet, John W. Eikelboom, Arend Mosterd, Stefan M. Nidorf, Charley A. Budgeon, Jan G. P. Tijssen, Peter L. Thompson, Cees J. Tack, Suat Simsek, Willem A. Bax, Jan H. Cornel, Saloua El Messaoudi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionDespite optimal treatment, patients with chronic coronary artery disease (CAD) and diabetes mellitus (DM) are at high risk of cardiovascular events, emphasizing the need for new treatment options. The Low-Dose Colchicine 2 (LoDoCo2) trial
Externí odkaz:
https://doaj.org/article/22bccdd36673494589e80219438b8e8b
Autor:
Max J. M. Silvis, Gerardus P. J. van Hout, Aernoud T. L. Fiolet, Mirthe Dekker, Lena Bosch, Martijn M. J. van Nieuwburg, Joyce Visser, Marlijn S. Jansen, Leo Timmers, Dominique P. V. de Kleijn
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Preclinical models that resemble the clinical setting as closely as possible are essential in translating promising therapies for the treatment of acute myocardial infarction. Closed chest pig left anterior descending coronary art
Externí odkaz:
https://doaj.org/article/48f72536db684e9796a4b598d6cc069d
Autor:
Amber van Broekhoven, Niekbachsh Mohammadnia, Max J. M. Silvis, Jonathan Los, Aernoud T. L. Fiolet, Tjerk S. J. Opstal, Arend Mosterd, John W. Eikelboom, Stefan M. Nidorf, Charley A. Budgeon, Elizabeth Byrnes, Willem A. Bax, Jan G. P. Tijssen, Dominique P. V. de Kleijn, Peter L. Thompson, Saloua El Messaoudi, Jan H. Cornel
Publikováno v:
Clinical drug investigation, 42(11), 977-985. Adis International Ltd
Clinical Drug Investigation, 42, 977-985
Clinical Drug Investigation, 42, 11, pp. 977-985
Clinical Drug Investigation, 42, 977-985
Clinical Drug Investigation, 42, 11, pp. 977-985
Contains fulltext : 288089.pdf (Publisher’s version ) (Open Access) BACKGROUND AND OBJECTIVE: The Low-Dose Colchicine-2 (LoDoCo2) trial showed that 2-4 years exposure to colchicine 0.5 mg once daily reduced the risk of cardiovascular events in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7e75f557f8750b00f611a1192bac17
https://research.vumc.nl/en/publications/94450c2a-4c60-47b0-a72e-c9b9f640b416
https://research.vumc.nl/en/publications/94450c2a-4c60-47b0-a72e-c9b9f640b416
Autor:
Amber, van Broekhoven, Niekbachsh, Mohammadnia, Max J M, Silvis, Jonathan, Los, Aernoud T L, Fiolet, Tjerk S J, Opstal, Arend, Mosterd, John W, Eikelboom, Stefan M, Nidorf, Charley A, Budgeon, Elizabeth, Byrnes, Willem A, Bax, Jan G P, Tijssen, Dominique P V, de Kleijn, Peter L, Thompson, Saloua, El Messaoudi, Jan H, Cornel
Publikováno v:
Clinical drug investigation. 42(11)
The Low-Dose Colchicine-2 (LoDoCo2) trial showed that 2-4 years exposure to colchicine 0.5 mg once daily reduced the risk of cardiovascular events in patients with chronic coronary artery disease. The potential effect of years-long exposure to colchi
Publikováno v:
Netherlands Heart Journal
Netherlands Heart Journal, 30, 1, pp. 25-37
Netherlands Heart Journal, 30, 25-37
Netherlands Heart Journal, 30, 1, pp. 25-37
Netherlands Heart Journal, 30, 25-37
Contains fulltext : 249997.pdf (Publisher’s version ) (Open Access) Patients with coronary disease remain at high risk for future cardiovascular events, even with optimal risk factor modification, lipid-lowering drugs and antithrombotic regimens. A
Autor:
Dominique P.V. de Kleijn, Max J. M. Silvis, Aernoud T L Fiolet, Lena Bosch, Joyce Mj Visser, Leo Timmers, Mirthe Dekker, Marlijn S Jansen, Martijn M. J. van Nieuwburg, Gerardus P.J. van Hout
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background Preclinical models that resemble the clinical setting as closely as possible are essential in translating promising therapies for the treatment of acute myocardial infarction. Closed chest pig left anterior descending coronary artery (LAD)
Autor:
Stefan M, Nidorf, Aernoud T L, Fiolet, Arend, Mosterd, John W, Eikelboom, Astrid, Schut, Tjerk S J, Opstal, Salem H K, The, Xiao-Fang, Xu, Mark A, Ireland, Timo, Lenderink, Donald, Latchem, Pieter, Hoogslag, Anastazia, Jerzewski, Peter, Nierop, Alan, Whelan, Randall, Hendriks, Henk, Swart, Jeroen, Schaap, Aaf F M, Kuijper, Maarten W J, van Hessen, Pradyot, Saklani, Isabel, Tan, Angus G, Thompson, Allison, Morton, Chris, Judkins, Willem A, Bax, Maurits, Dirksen, Marco, Alings, Graeme J, Hankey, Charley A, Budgeon, Jan G P, Tijssen, Jan H, Cornel, Peter L, Thompson, Karen, Youl
Publikováno v:
LoDoCo2 Trial Investigators 2020, ' Colchicine in patients with chronic coronary disease ', New England Journal of Medicine, vol. 383, no. 19, pp. 1838-1847 . https://doi.org/10.1056/NEJMoa2021372
The New England Journal of Medicine, 383, 1838-1847
The New England Journal of Medicine, 383, 19, pp. 1838-1847
New England journal of medicine, 383(19), 1838-1847. Massachussetts Medical Society
New England Journal of Medicine, 383(19), 1838-1847. Massachussetts Medical Society
The New England Journal of Medicine, 383, 1838-1847
The New England Journal of Medicine, 383, 19, pp. 1838-1847
New England journal of medicine, 383(19), 1838-1847. Massachussetts Medical Society
New England Journal of Medicine, 383(19), 1838-1847. Massachussetts Medical Society
Evidence from a recent trial has shown that the antiinflammatory effects of colchicine reduce the risk of cardiovascular events in patients with recent myocardial infarction, but evidence of such a risk reduction in patients with chronic coronary dis
Autor:
Myrthe C, van der Burg, Jan-Willem, Balder, Joop J G, van den Brand, Sander, van Gulik, Aernoud T L, Fiolet
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 165
Non-bacterial thrombotic endocarditis (NBTE), also known as non-infective endocarditis, is a rare condition characterised by formation of sterile fibrin and platelet depositions on heart valves. NBTE is commonly seen in advanced malignancies, auto-im
Autor:
Jetske van 't Sant, Aernoud T L Fiolet, Iris A H ter Horst, Maarten J Cramer, Mirjam H Mastenbroek, Wouter M van Everdingen, Thomas P Mast, Pieter A Doevendans, Henneke Versteeg, Mathias Meine
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0124323 (2015)
Response to cardiac resynchronization therapy (CRT) is often assessed six months after implantation. Our objective was to assess the number of patients changing from responder to non-responder between six and 14 months, so-called late non-responders,
Externí odkaz:
https://doaj.org/article/f0b245c982e3422081c53d4c1aed1933
Autor:
Charley A. Budgeon, Tjerk S.J. Opstal, Arend Mosterd, Stefan M. Nidorf, Jan H. Cornel, Jan G.P. Tijssen, Peter L. Thompson, John W. Eikelboom, Aernoud T L Fiolet
Publikováno v:
European Heart Journal-Cardiovascular Pharmacotherapy, 7(4). Oxford University Press
European Heart Journal-Cardiovascular Pharmacotherapy, 7, 4
European Heart Journal-Cardiovascular Pharmacotherapy, 7
European heart journal. Cardiovascular pharmacotherapy, 7(4). Oxford University Press
Fiolet, A T L, Opstal, T S J, Mosterd, A, Eikelboom, J W, Nidorf, S M, Thompson, P L, Budgeon, C, Tijssen, J G P & Cornel, J H 2021, ' Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underlying possible safety concerns ', European heart journal. Cardiovascular pharmacotherapy, vol. 7, no. 4, pp. E71 . https://doi.org/10.1093/ehjcvp/pvab019
European Heart Journal-Cardiovascular Pharmacotherapy, 7, 4
European Heart Journal-Cardiovascular Pharmacotherapy, 7
European heart journal. Cardiovascular pharmacotherapy, 7(4). Oxford University Press
Fiolet, A T L, Opstal, T S J, Mosterd, A, Eikelboom, J W, Nidorf, S M, Thompson, P L, Budgeon, C, Tijssen, J G P & Cornel, J H 2021, ' Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underlying possible safety concerns ', European heart journal. Cardiovascular pharmacotherapy, vol. 7, no. 4, pp. E71 . https://doi.org/10.1093/ehjcvp/pvab019
Contains fulltext : 238802.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d90d17fad18465e0e735472d6405134
https://pure.amc.nl/en/publications/letter-to-the-editor-colchicine-and-risk-of-noncardiovascular-death-in-patients-with-coronary-artery-disease-a-pooled-analysis-underlying-possible-safety-concerns(d648226f-8902-47dd-b406-af0a60ba2345).html
https://pure.amc.nl/en/publications/letter-to-the-editor-colchicine-and-risk-of-noncardiovascular-death-in-patients-with-coronary-artery-disease-a-pooled-analysis-underlying-possible-safety-concerns(d648226f-8902-47dd-b406-af0a60ba2345).html